Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Inspired Entertainment
INSE
$175M
| $4.84M | ﹤0.01% |
521,451
+4,233
| +0.8% | +$37.5K |
|
|
EB
2777
DELISTED
Eventbrite
EB
| $4.83M | ﹤0.01% |
1,767,144
-80,812
| -4% | -$307K |
|
|
SHCR
2778
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $4.82M | ﹤0.01% |
3,392,453
+126,020
| +4% | +$175K |
|
2779
PCB Bancorp
PCB
$391M
| $4.81M | ﹤0.01% |
255,959
+1,751
| +0.7% | +$31.5K |
|
2780
Gencor Industries
GENC
$212M
| $4.81M | ﹤0.01% |
230,324
+4,064
| +2% | +$82K |
|
|
ARTV
2781
Artiva Biotherapeutics
ARTV
$551M
| $4.77M | ﹤0.01% |
+308,930
| New | +$3.58M |
|
|
MBCN
2782
DELISTED
Middlefield Banc Corp
MBCN
| $4.76M | ﹤0.01% |
165,355
+1,368
| +0.8% | +$35.2K |
|
2783
Wheels Up
UP
$198M
| $4.76M | ﹤0.01% |
98,264
+35,921
| +58% | +$1.75M |
|
2784
Zentalis Pharmaceuticals
ZNTL
$302M
| $4.76M | ﹤0.01% |
1,292,100
-42,359
| -3% | -$154K |
|
2785
Ring Energy
REI
$339M
| $4.75M | ﹤0.01% |
2,970,929
+763,907
| +35% | +$1.37M |
|
2786
Greif Class B
GEF.B
$4.21B
| $4.73M | ﹤0.01% |
67,747
-3,065
| -4% | -$202K |
|
2787
Fulcrum Therapeutics
FULC
$297M
| $4.72M | ﹤0.01% |
1,320,862
+13,485
| +1% | +$100K |
|
|
WBTN
2788
WEBTOON Entertainment Inc
WBTN
$1.21B
| $4.72M | ﹤0.01% |
412,131
+306,496
| +290% | +$4.86M |
|
|
BOW
2789
Bowhead Specialty Holdings
BOW
$1.1B
| $4.69M | ﹤0.01% |
+167,433
| New | +$4.7M |
|
2790
Medifast
MED
$141M
| $4.68M | ﹤0.01% |
244,482
-36,328
| -13% | -$700K |
|
|
NVRO
2791
DELISTED
NEVRO CORP.
NVRO
| $4.67M | ﹤0.01% |
835,204
+612
| +0.1% | +$4.28K |
|
2792
FVCBankcorp
FVCB
$333M
| $4.67M | ﹤0.01% |
357,570
+4,820
| +1% | +$56.6K |
|
2793
iHeartMedia
IHRT
$583M
| $4.65M | ﹤0.01% |
2,515,516
+137,896
| +6% | +$205K |
|
2794
MacroGenics
MGNX
$257M
| $4.63M | ﹤0.01% |
1,406,876
-8,363
| -0.6% | -$32.6K |
|
|
BLFY
2795
DELISTED
Blue Foundry Bancorp
BLFY
| $4.63M | ﹤0.01% |
451,586
-17,356
| -4% | -$180K |
|
2796
Karat Packaging
KRT
$940M
| $4.63M | ﹤0.01% |
178,645
+24,020
| +16% | +$644K |
|
|
PSTX
2797
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $4.63M | ﹤0.01% |
1,617,137
-5,438
| -0.3% | -$16.8K |
|
|
URG
2798
Ur-Energy
URG
$556M
| $4.63M | ﹤0.01% |
3,886,655
+695,487
| +22% | +$831K |
|
2799
BARK
BARK
$101M
| $4.62M | ﹤0.01% |
141,579
+9,321
| +7% | +$303K |
|
2800
W&T Offshore
WTI
$518M
| $4.62M | ﹤0.01% |
2,146,569
+52,186
| +2% | +$116K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.